DOI QR코드

DOI QR Code

Age is Important, but Patient Status is also Important in Endoscopic Retrograde Cholangiopancreatography

  • Lee, Dong Wook (Division of Gastroenterology, Department of Internal Medicine, Catholic University of Daegu School of Medicine) ;
  • Kim, Ho Gak (Division of Gastroenterology, Department of Internal Medicine, Catholic University of Daegu School of Medicine)
  • 투고 : 2018.07.12
  • 심사 : 2018.07.15
  • 발행 : 2018.07.30

초록

키워드

참고문헌

  1. Harness JK, Strodel WE, Talsma SE. Symptomatic biliary tract disease in the elderly patient. Am Surg 1986;52:442-445.
  2. Farrell RJ, Mahmud N, Noonan N, Kelleher D, Keeling PW. Diagnostic and therapeutic ERCP: a large single centre's experience. Ir J Med Sci 2001;170:176-180. https://doi.org/10.1007/BF03173884
  3. Yun DY, Han J, Oh JS, Park KW, Shin IH, Kim HG. Is endoscopic retrograde cholangiopancreatography safe in patients 90 years of age and older? Gut Liver 2014;8:552-556. https://doi.org/10.5009/gnl13310
  4. Sugiyama M, Atomi Y. Endoscopic sphincterotomy for bile duct stones in patients 90 years of age and older. Gastrointest Endosc 2000;52:187-191. https://doi.org/10.1067/mge.2000.107285
  5. Katsinelos P, Paroutoglou G, Kountouras J, Zavos C, Beltsis A, Tzovaras G. Efficacy and safety of therapeutic ERCP in patients 90 years of age and older. Gastrointest Endosc 2006;63:417-423. https://doi.org/10.1016/j.gie.2005.09.051
  6. Hu L, Sun X, Hao J, et al. Long-term follow-up of therapeutic ERCP in 78 patients aged 90 years or older. Sci Rep 2014;4:4918.
  7. Sobani ZA, Yunina D, Abbasi A, et al. Endoscopic retrograde cholangiopancreatography in nonagenarian patients: is it really safe? Clin Endosc 2018;51:375-380. https://doi.org/10.5946/ce.2017.123
  8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. https://doi.org/10.1016/0021-9681(87)90171-8
  9. Sarfati D, Tan L, Blakely T, Pearce N. Comorbidity among patients with colon cancer in New Zealand. N Z Med J 2011;124:76-88.
  10. Mnatzaganian G, Ryan P, Norman PE, Hiller JE. Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality. J Clin Epidemiol 2012;65:107-115. https://doi.org/10.1016/j.jclinepi.2011.03.014
  11. West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 1996;6:413-419. https://doi.org/10.1016/S1047-2797(96)00096-8
  12. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003;56:221-229. https://doi.org/10.1016/S0895-4356(02)00585-1
  13. Chen YY, Yen HH, Soon MS. Impact of endoscopy in the management of duodenal diverticular bleeding: experience of a single medical center and a review of recent literature. Gastrointest Endosc 2007;66:831-835. https://doi.org/10.1016/j.gie.2007.06.001
  14. Afridi SA, Fichtenbaum CJ, Taubin H. Review of duodenal diverticula. Am J Gastroenterol 1991;86:935-938.
  15. Boix J, Lorenzo-Zunig V, Ananos F, Domenech E, Morillas RM, Gassull MA. Impact of periampullary duodenal diverticula at endoscopic retrograde cholangiopancreatography: a proposed classification of periampullary duodenal diverticula. Surg Laparosc Endosc Percutan Tech 2006;16:208-211. https://doi.org/10.1097/00129689-200608000-00002
  16. Gronroos JM, Salminen P, Laine S, Gullichsen R. Feasibility of ERCP procedures in patients 90 years of age and older. J Clin Gastroenterol 2010;44:227-228. https://doi.org/10.1097/MCG.0b013e3181b3830f
  17. Mitchell RM, O'Connor F, Dickey W. Endoscopic retrograde cholangiopancreatography is safe and effective in patients 90 years of age and older. J Clin Gastroenterol 2003;36:72-74. https://doi.org/10.1097/00004836-200301000-00019

피인용 문헌

  1. Process and Renewal of Pancreatobiliary Cerification System vol.25, pp.1, 2020, https://doi.org/10.15279/kpba.2020.25.1.1